Literature DB >> 8822924

Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain.

T M Odrljin1, J R Shainoff, S O Lawrence, P J Simpson-Haidaris.   

Abstract

Thrombin (IIa)-cleavage of fibrinogen (FBG) to form polymerized fibrin promotes endothelial cell spreading, proliferation, and von Willebrand factor release, requiring the exposure of the beta 15-42 domain. Studies reported here indicate that IIa-cleavage of fibrinopeptide B enhances exposure of a heparin binding domain at the beta 15-42 neo-N-terminus of fibrin. Crossed immunoelectrophoresis showed heparin-induced mobility shifts indicative of complexing with FBG and with N-terminal CNBr fragments of FBG (NDSK) and of fibrin (IIa-NDSK), but not evidence of heparin complexing with FBG lacking B beta 1-42 or with FBG fragments D and E was seen. Elution from heparin-agarose with a linear gradient of NaCl showed that bound portions of both intact FBG and D fragments eluted below physiologic salt concentrations, whereas E3 fragments lacking B beta 1-53 did not bind. NDSK bound with higher affinity than did intact FBG, whereas binding of IIa-NDSK was maximal in this system. Binding of fibrin(ogen) to heparin agarose was saturable as well as inhibitable in a dose-dependent manner with both FBG and heparin. Scatchard analysis indicated a single class of binding site, with dissociation constants (kd) of 0.3 mumol/L for IIa-NDSK, 0.8 mumol/L for NDSK, and 18 mumol/L for FBG. Immobilized fibrin had twofold more heparin binding sites than did immobilized FBG and required a 5.5-fold higher concentration of heparin to inhibit by 50% the binding of labeled heparin. Together, the results indicate that IIa-cleavage results in enhanced exposure of two heparin binding domains (HBDs) with approximately threefold higher affinity in fibrin than in FBG. Synthetic peptide beta 15-42 showed highest binding to heparin-agarose followed by B beta 1-42, whereas peptides beta 18-31, beta 18-27, and beta 24-42 did not bind. Thus, the primary structure of beta 15-42 is required for specificity of heparin binding. Basic residues within the beta 15-32 region segregate primarily to one side of an alpha-helix in a helical wheel diagram, as is typical for authentic HBDs. Desulfated heparin and heparan sulfate bound more fibrin(ogen) than did other proteoglycans; however, heparin bound sixfold more Ila-NDSK than NDSK. These results confirm that fibrin binds to heparin with higher affinity than does FBG and that fibrin binding is not solely dependent on charge interactions of beta 15-42 with the negatively charged glycosaminoglycan.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822924

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.

Authors:  James C Fredenburgh; Beverly A Leslie; Alan R Stafford; Teresa Lim; Howard H Chan; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

2.  Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.

Authors:  Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

3.  Single-molecule binding of CD44 to fibrin versus P-selectin predicts their distinct shear-dependent interactions in cancer.

Authors:  Phrabha S Raman; Christina S Alves; Denis Wirtz; Konstantinos Konstantopoulos
Journal:  J Cell Sci       Date:  2011-05-10       Impact factor: 5.285

4.  Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.

Authors:  P J Simpson-Haidaris; M A Courtney; T W Wright; R Goss; A Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Fibrinogen Protects Against Barrier Dysfunction Through Maintaining Cell Surface Syndecan-1 In Vitro.

Authors:  Feng Wu; Rosemary A Kozar
Journal:  Shock       Date:  2019-06       Impact factor: 3.454

6.  Novel osteoinductive photo-cross-linkable chitosan-lactide-fibrinogen hydrogels enhance bone regeneration in critical size segmental bone defects.

Authors:  Sungwoo Kim; Katherine Bedigrew; Teja Guda; William J Maloney; Sangwon Park; Joseph C Wenke; Yunzhi Peter Yang
Journal:  Acta Biomater       Date:  2014-08-28       Impact factor: 8.947

7.  Polyphosphate enhances fibrin clot structure.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

Review 8.  Resuscitative Strategies to Modulate the Endotheliopathy of Trauma: From Cell to Patient.

Authors:  Feng Wu; Amanda Chipman; Shibani Pati; Byron Miyasawa; Laurence Corash; Rosemary A Kozar
Journal:  Shock       Date:  2020-05       Impact factor: 3.533

9.  Missing regions within the molecular architecture of human fibrin clots structurally resolved by XL-MS and integrative structural modeling.

Authors:  Oleg Klykov; Carmen van der Zwaan; Albert J R Heck; Alexander B Meijer; Richard A Scheltema
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-10       Impact factor: 11.205

10.  Autologous Platelet Rich Plasma (PRGF) Preserves Genomic Stability of Gingival Fibroblasts and Alveolar Osteoblasts after Long-Term Cell Culture.

Authors:  Eduardo Anitua; María de la Fuente; María Troya; Mar Zalduendo; Mohammad Hamdan Alkhraisat
Journal:  Dent J (Basel)       Date:  2022-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.